Get the Stockscreener App
3.18
6.74%
-0.23
Pre-market:
3.39
0.21
+6.60%
Tivic Health Systems Inc stock is traded at $3.18, with a volume of 21,478.
It is down -6.74% in the last 24 hours and down -75.18% over the past month.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
See More
Previous Close:
$3.41
Open:
$3.41
24h Volume:
21,478
Relative Volume:
0.03
Market Cap:
$1.95M
Revenue:
$957.00K
Net Income/Loss:
$-6.42M
P/E Ratio:
-1.0292
EPS:
-3.0899
Net Cash Flow:
$-6.13M
1W Performance:
-26.87%
1M Performance:
-75.18%
6M Performance:
-34.64%
1Y Performance:
-85.72%
1-Day Range:
$3.15
$3.49
1-Week Range:
$2.8501
$4.38
52-Week Range:
$2.8501
$31.45
Tivic Health Systems Inc Stock (TIVC) Company Profile
Name
Tivic Health Systems Inc
Sector
Industry
Phone
(888)276-6888
Address
47685 LAKEVIEW BLVD, FREMONT
Compare TIVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
3.18 | 1.95M | 957.00K | -6.42M | -6.13M | -3.0899 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Tivic Health Systems Inc Stock (TIVC) Latest News
Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast - Joplin Globe
Tivic Health Q4 Earnings Preview: Key Financial Results Coming March 21 - StockTitan
Tivic Health Systems, Inc. (NASDAQ:TIVC) Short Interest Down 99.1% in February - Defense World
Tivic Health announces reverse stock split - MSN
Tivic Health stock hits 52-week high at $4.35 amid market fluctuations - Investing.com Canada
Tivic Health Systems Stock Price, Quotes and Forecasts | NASDAQ:TIVC - Benzinga
Tivic Health unveils ncVNS device data for chronic disorders By Investing.com - Investing.com Canada
Tivic Health unveils ncVNS device data for chronic disorders - Investing.com
Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System - Joplin Globe
Can Personalized Vagus Nerve Stimulation Transform Neurological Treatment? New Clinical Data Reveals Key Insights - StockTitan
Tivic Health enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Tivic Health Systems Announces Reverse Stock Split - TipRanks
Tivic Health Systems, Inc. Announces Reverse Stock Split - BioSpace
Tivic Health enacts reverse stock split to meet Nasdaq requirements - Investing.com India
Can Tivic Health's Drastic 1-for-17 Reverse Split Save Its Nasdaq Status? - StockTitan
Breaking down TIVC’s current quarter earnings estimates - US Post News
Tivic Health files patent for personalized VNS device By Investing.com - Investing.com Canada
Tivic Health files patent for personalized VNS device - Investing.com
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - The Bakersfield Californian
Can Tivic Health's New Vagus Nerve Patent Transform Neurostimulation Treatment? - StockTitan
Tivic Health Systems, Inc. (NASDAQ:TIVC) Short Interest Up 1,818.2% in February - Defense World
Tivic Health Systems Appoints New COO and President - TipRanks
Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team - Milton Daily Standard
Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now - News & Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist - The Globe and Mail
Tivic Health Systems, Inc. (Nasdaq: TIVC) Makes NASDSAQ Top Gainers List on Licensing News - Investorideas.com newswire
Tivic Health Systems rises after deal for late-stage immunotherapy drug - TradingView
Stock market news: Kindly MD surged by 227.10% while Spire Global plunged by 52.39% during midday trading - Business Upturn
Tivic Health shareholders approve reverse stock split proposal - MSN
Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings - Benzinga
Stock market today: Spire Global plunged by 48.97% while Xilio Therapeutics surged by 102.16% in early trading - Business Upturn
Dow Dips Over 300 Points; US Inflation Increases More Than Expected - Benzinga
Tivic Health Systems Secures Licensing Agreement with Statera - TipRanks
Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist -February 12, 2025 at 08:34 am EST - Marketscreener.com
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
Tivic Health Systems Inc (NASDAQ:TIVC) Up 16.67% Since 52-Week Low; YTD Fall -29.84% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel
Tivic Health shareholders approve reverse stock split proposal By Investing.com - Investing.com South Africa
Enrollment Complete in Tivic Health’s VNS Device Trial - MPO-mag
Tivic Health faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Tivic Health faces potential Nasdaq delisting - Investing.com
Tivic Health Validates European Patents - MPO-mag
Tivic Health Systems Inc Stock (TIVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):